HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.

Abstract
1. Increased rates of fatty acid oxidation are frequently observed in patients with non-insulin-dependent diabetes mellitus and may contribute to hyperglycaemia by both decreasing peripheral glucose disposal and, more importantly, by increasing the rate of gluconeogenesis and therefore hepatic glucose output. Despite this relationship between lipid and carbohydrate metabolism, fasting glucose concentrations do not fall acutely in patients with non-insulin-dependent diabetes mellitus when plasma non-esterified fatty acid concentrations and lipid oxidation rates are decreased, questioning the importance of this interaction to glycaemic control. We have therefore measured the acute changes that occur 120-150 min after administration of 500 mg of the antilipolytic agent acipimox in eight non-obese male patients with non-insulin-dependent diabetes mellitus. 2. After administration of acipimox, lipolysis was inhibited as reflected by lower plasma non-esterified fatty acid (0.05 +/- 0.02 versus 0.55 +/- 0.05 mmol/l, P less than 0.001) and blood glycerol (8 +/- 1 versus 56 +/- 8 mumol/l, P less than 0.001) concentrations. The lipid oxidation rate was decreased (0.63 +/- 0.05 versus 1.02 +/- 0.08 mg min-1 kg-1, P less than 0.001), whereas there was a significant increase in the carbohydrate oxidation rate (1.93 +/- 0.17 versus 1.22 +/- 0.18 mg min-1 kg-1, P = 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsG R Fulcher, M Walker, C Catalano, M Farrer, K G Alberti
JournalClinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 82 Issue 5 Pg. 565-71 (May 1992) ISSN: 0143-5221 [Print] England
PMID1317767 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Hydroxybutyrates
  • Hypolipidemic Agents
  • Pyrazines
  • Glucagon
  • acipimox
  • Glycerol
  • 3-Hydroxybutyric Acid
  • Hydrocortisone
  • Norepinephrine
  • Epinephrine
Topics
  • 3-Hydroxybutyric Acid
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (blood)
  • Epinephrine (blood)
  • Fatty Acids, Nonesterified (blood)
  • Glucagon (blood)
  • Glycerol (blood)
  • Humans
  • Hydrocortisone (blood)
  • Hydroxybutyrates (blood)
  • Hypolipidemic Agents (pharmacology)
  • Lipolysis (drug effects)
  • Male
  • Middle Aged
  • Norepinephrine (blood)
  • Pyrazines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: